Fig. 7From: Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistanceKEGG pathway analysis results showing differentially abundant m6A marks between CR and non-CR patients. A circRNAs in CR patients, B circRNAs in non-CR patients, C lncRNAs in CR patients, D lncRNAs in non-CR patients, E mRNAs in CR patients, and F mRNAs in non-CR patientsBack to article page